Urban Novak

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Human ΔNp73 regulates a dominant negative feedback loop for TAp73 and p53

Tobias Grob, Urban Novak, Carine Maisse et al. · Cell Death and Differentiation · 2001 · 336 citations

Life Sciences, Genetics, Molecular Biology +8

Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial

Andrew Davies, Thomas Cummin, Sharon Barrans et al. · The Lancet Oncology · 2019 · 272 citations · Full text

Medicine, Hematology, Oncology +15

The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas

Urban Novak, Andrea Rinaldi, Ivo Kwee et al. · Blood · 2009 · 242 citations · Full text

Medicine, Molecular Biology, Molecular Genetics +17

BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma

Masumichi Saito, Urban Novak, Erich Piovan et al. · Proceedings of the National Academy of Sciences · 2009 · 193 citations · Full text

Life Sciences, Molecular Biology, Oncology +17